New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 10, 2014
08:26 EDTGEVA, ICPTLeerink reiterates caution on Intercept ahead of FLINT data
Leerink says the physicians it spoke to at its Healthcare Insights Conference who treat liver diseases were cautious on Intercept's (ICPT) obeticholic acid's clinical potential in non-alcoholic steatohepatitis due to its effect on LDL-C. Leerink remains cautious on the stock ahead of full FLINT data in the second half of 2014, as it believes there is as much if not more downside than upside due to safety concerns. The firm adds the specialists noted that they have screened and not found any patients that warrant treatment with an expensive enzyme replacement therapy, such as Synageva's (GEVA) sebelipase alfa.
News For ICPT;GEVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 6, 2015
17:03 EDTGEVAOn The Fly: Top stock stories for Wednesday
Subscribe for More Information
13:28 EDTGEVAOn The Fly: Top stock stories at midday
Subscribe for More Information
11:02 EDTGEVASynageva acquisition a good deal for Alexion, says Piper Jaffray
Subscribe for More Information
10:15 EDTGEVAHigh option volume stocks
High option volume stocks: WEN GEVA EXPD BKLN NDLS KRE TNET FXCM PWRD EA
09:16 EDTGEVAOn The Fly: Pre-market Movers
Subscribe for More Information
08:24 EDTGEVAAlexion to host conference call
Subscribe for More Information
08:07 EDTGEVABioMarin up 4% to $118 after Synageva takeout
Subscribe for More Information
07:57 EDTGEVASynageva volatility flat into Alexion acquiring for $230 per share
Subscribe for More Information
07:38 EDTGEVAAlexion volatility flat into acquiring Synageva for $230 per share
Subscribe for More Information
06:45 EDTGEVAAlexion agrees to acquire Synageva in transaction valued at $8.4B net of cash
Subscribe for More Information
06:43 EDTGEVAAlexion agrees to acquire Synageva in transaction valued at $8.4B net of cash
Subscribe for More Information
May 1, 2015
07:33 EDTICPTIntercept management to meet with Deutsche Bank
Subscribe for More Information
April 29, 2015
16:34 EDTGEVASynageva reports Q1 EPS ($1.63), consensus ($1.70)
Subscribe for More Information
April 23, 2015
05:44 EDTICPTIntercept FLINT trial data shows OCA treatment increases fibrosis resolution
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use